These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 36518628)
1. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer. Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer. Han C; Deng Y; Yang B; Hu P; Hu B; Wang T; Liu J; Xia Q; Liu X Front Immunol; 2023; 14():1126902. PubMed ID: 36891298 [TBL] [Abstract][Full Text] [Related]
3. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer. Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD Front Immunol; 2022; 13():908068. PubMed ID: 35898492 [TBL] [Abstract][Full Text] [Related]
4. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer. Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300 [TBL] [Abstract][Full Text] [Related]
5. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer. Liu B; Fu T; He P; Du C; Xu K Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198 [TBL] [Abstract][Full Text] [Related]
6. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer. Ping L; Zhang K; Ou X; Qiu X; Xiao X Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734 [No Abstract] [Full Text] [Related]
7. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y Front Immunol; 2023; 14():1128390. PubMed ID: 36761753 [TBL] [Abstract][Full Text] [Related]
8. Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma: a bioinformatic analysis. Lai T; Li F; Xiang L; Liu Z; Li Q; Cao M; Sun J; Hu Y; Liu T; Liang J Transl Cancer Res; 2024 Sep; 13(9):4786-4799. PubMed ID: 39430830 [TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a prognostic prediction system based on tumor microenvironment of pancreatic cancer. Feng Y; Li P; Yang F; Xu K Medicine (Baltimore); 2022 Dec; 101(51):e32364. PubMed ID: 36595826 [TBL] [Abstract][Full Text] [Related]
11. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma. Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer. Zhang X; Shi X; Zhao H; Jia X; Yang Y Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055 [TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
14. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis. Cai Y; Wang X; Wang N; Wu J; Ma L; Xie X; Zhang H; Dang C; Kang H; Zhang S; Zhou Z Life Sci; 2021 Jul; 277():119505. PubMed ID: 33872662 [TBL] [Abstract][Full Text] [Related]
15. Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer. Zhou Y; Xiao L; Long G; Cao J; Liu S; Tao Y; Zhou L; Tang J Front Immunol; 2022; 13():921182. PubMed ID: 36072578 [TBL] [Abstract][Full Text] [Related]
16. Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma. Ye Y; Luo Y; Guo T; Zhang C; Sun Y; Xu A; Ji L; Ou J; Wu SY Front Endocrinol (Lausanne); 2023; 14():1179050. PubMed ID: 37600707 [TBL] [Abstract][Full Text] [Related]
17. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer. Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer. Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]